Concepedia

Author

LeRoy LeNarz

Eli Lilly (United States)

Also Known As

L LeNarz, L.A. LeNarz, LeRoy A LeNarz, LeRoy A. LeNarz, LeRoy LeNarz, LeRoy Lenarz, Leroy A LeNarz, Leroy Lenarz, V. Legrand

30

Publications

954

Citations

12

H-Index

19

Concepts

All Affiliations

Eli Lilly (United States)Charles UniversitySorbonne UniversitéJagiellonian UniversityAzienda Usl 8 Arezzo
LL

About

LeRoy LeNarz is an author at Eli Lilly (United States) specializing in percutaneous coronary intervention, coronary heart disease, and cardiovascular disease.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

779

2

Percutaneous Coronary Intervention

7

7

779

3

Emergency Medicine

3

3

141

4

Clinical Sciences

1

1

15

5

Vascular Surgery

1

1

92

LeRoy LeNarz

×

11

Publications

897

Citations

11

H-Index

YearCitations

Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease

David E. Kandzari, Martin B. Leon, Jeffrey J. Popma,

Journal of the American College of Cardiology

2006

346

Mortality Benefit With Prasugrel in the TRITON–TIMI 38 Coronary Artery Bypass Grafting Cohort

Peter K. Smith, Lawrence T. Goodnough, Jerrold H. Levy,

Journal of the American College of Cardiology

2012

199

Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials

A. Michael Lincoff, LeRoy LeNarz, George J. Despotis,

The Annals of Thoracic Surgery

2000

92

Effect of Prasugrel Pre-Treatment Strategy in Patients Undergoing Percutaneous Coronary Intervention for NSTEMI

Gilles Montalescot, Jean‐Philippe Collet, Patrick Ecollan,

Journal of the American College of Cardiology

2014

73

Improved graft patency associated with altered platelet function induced by marine fatty acids in dogs

Robert E. Casali, Janet A. Hale, LeRoy LeNarz,

Journal of Surgical Research

1986

45

Factors associated with clopidogrel use, adherence, and persistence in patients with acute coronary syndromes undergoing percutaneous coronary intervention

Baojin Zhu, Zhenxiang Zhao, Patrick L. McCollam,

Current Medical Research and Opinion

2011

39

Impact of Access Site on Bleeding and Ischemic Events in Patients With Non–ST-Segment Elevation Myocardial Infarction Treated With Prasugrel

Italo Porto, Leonardo Bolognese, Dariusz Dudek,

JACC: Cardiovascular Interventions

2016

30

Transfusion outcomes in patients undergoing coronary artery bypass grafting treated with prasugrel or clopidogrel: TRITON-TIMI 38 retrospective data analysis

Lawrence T. Goodnough, Peter K. Smith, Jerrold H. Levy,

Journal of Thoracic and Cardiovascular Surgery

2012

20

Predictors of bleeding in patients with acute coronary syndromes treated with prasugrel

Petr Widimský, Zuzana Moťovská, Leonardo Bolognese,

Heart

2015

19

Impact of prasugrel pretreatment and timing of coronary artery bypass grafting on clinical outcomes of patients with non-ST-segment elevation myocardial infarction: From the A Comparison of Prasugrel at PCI or Time of Diagnosis of Non–ST-Elevation Myocardial Infarction (ACCOAST) study

Dariusz Dudek, Artur Dziewierz, Petr Widimský,

American Heart Journal

2015

19

Page 1